期刊文献+

高原地区上消化道疾病幽门螺杆菌菌型的临床研究 被引量:3

Clinical Study on biotypes of Helicobacter pylori in patients with digestive disorders in plateau region of China
暂未订购
导出
摘要 目的研究高原地区上消化道疾病幽门螺杆菌(Helicobacter pylori,Hp)菌型。方法应用Hp尿素酶基因(ure)和细胞毒(cagA)基因引物对330例上消道疾病患者通过聚合酶链反应(PCR)技术,检测ure和cagA基因阳性检出率;用免疫印迹法检测血清ure和CagA抗体。结果 Hp菌株ure和cagA基因阳性检出率分别为90.0%和82.4%;Ure和CagA抗体阳性率分别为89.3%和63.6%;ure和cagA基因表达率分别为99.3%和77.2%。结论高原地区消化道疾病患者中HpcagA基因阳性率较高,CagA蛋白,CagA抗体(Ⅰ型Hp)的表达率亦相应增高。 Objective To study the biotypes of Helicobacter pylori(H.pylori) in plateau region of China. Methods DNA fragments of urease and cagA gene from 330 gastric biopsy specimens were amplified by PCR.Serum urease and CagA antibody of the patients with digestive disorders with H.pylori infection was examined by Western blot. Results The positive rates of urease and cagA genes were 90.0% and 82.4%, respectively. The positive rates of serum urease and CagA antibody were 89.3% and 63.6%, respectively. The expression rates of urease and cagA genes were 99.3% and 77.2%, respectively. Conclusions There is a higher positive rate of serum CagA antibody (Type I H.pylori) in plateau region of China.
出处 《现代消化及介入诊疗》 2011年第4期224-226,230,共4页 Modern Interventional Diagnosis and Treatment in Gastroenterology
关键词 上消化道疾病 幽门螺杆菌 菌型 尿素酶 细胞毒相关蛋白 Upper gastrointestinal diseases Helicobacter pylori biotypes Urease Cytotoxin associated protein
  • 相关文献

参考文献4

二级参考文献21

  • 1徐智民,潘俊辉,宋卫生,孙勇,赖卓胜,王亚东,张万岱.幽门螺杆菌尿素酶金标抗体检查法与^(14)C-尿素呼气试验检测幽门螺杆菌感染的对照研究[J].现代消化及介入诊疗,2003,8(3):156-157. 被引量:2
  • 2李瑜元 胡品津 见:胡伏莲 周殿元 主编.幽门螺杆菌的流行病学[A].见:胡伏莲,周殿元,主编.幽门螺杆菌感染的基础与临床(修订版)[C].北京:中国科学技术出版社,2002.47—53.
  • 3International Agency for Research on Cancer,World Health Organization.Schistosomes,liver flukes and Helicobacter pylori.1ARC Working Group on the Evaluation of Carcinogenic Risks to Humans,1994.IARC Monogr Eval Carcinog Risks Hum,1994,61:1-241.
  • 4Parsonnet J,Hansen S,Rodriguez L,et al.Helicobacter pylori infection and gastric lyphoma.N Engl J Med,1994,330:1267-1270.
  • 5ParsonnerJ.The incidence of Helicobacter pylori inefectioa.Aliment Pharmacol Ther,1995,9(suppl 2):45-51.
  • 6Drumm B,Perez-perez GI,Blaser MJ,et al.Intrafamilar culstering of Helicobacter pylori infection.N Engl Med..1990,322:359-363.
  • 7Higashi H, Tsutsumi R, Muto S, et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science, 2002,295:683-686.
  • 8Higashi H, Tsutsumi R, Fujita A, et al. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci USA,2002,99:14428-14433.
  • 9Segal ED, Cha J, Lo J, et al. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc Natl Acad Sci USA, 1999, 96: 14559-14564.
  • 10Stein M, Bagnoli F, Halenbeck R, et al. c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol Microbiol, 2002,43:971-980.

共引文献1099

同被引文献29

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部